Lv3
275 积分 2022-04-03 加入
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
1个月前
已完结
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study
1个月前
已完结
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer
1个月前
已完结
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
1个月前
已完结
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer
1个月前
已完结
Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options
1个月前
已完结
Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options
1个月前
已完结
Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options
1个月前
已完结
Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options
1个月前
已完结
Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options
1个月前
已关闭
皖公网安备34019202002308
